BRIEF published on 02/20/2026 at 06:35, 1 month 6 days ago Siegfried AG affiche une forte croissance financière malgré les difficultés Performance Financière Stratégie De Croissance Investissement Stratégique Efficacité Opérationnelle Perspectives 2026
BRIEF published on 02/20/2026 at 06:35, 1 month 6 days ago Siegfried AG Exhibits Strong Financial Growth Amid Challenges Growth Strategy Financial Performance Operational Efficiency Strategic Investment 2026 Outlook
PRESS RELEASE published on 02/20/2026 at 06:30, 1 month 7 days ago Siegfried delivers strong profitability and continued growth Siegfried reports strong financial performance in 2025, achieving profitable growth and strategic acquisitions. Core EBITDA margin exceeded 23% Financial Performance CORE EBITDA Margin Profitable Growth Strategic Acquisitions Siegfried
BRIEF published on 02/05/2026 at 06:35, 1 month 21 days ago Siegfried AG annonce les nominations à son conseil d'administration Industrie Pharmaceutique Nominations Au Conseil D'administration Siegfried AG Thomas Wozniewski Karl Petersson
BRIEF published on 02/05/2026 at 06:35, 1 month 21 days ago Siegfried AG Announces Board of Directors Nominations Pharmaceutical Industry Board Nominations Siegfried AG Thomas Wozniewski Karl Petersson
PRESS RELEASE published on 02/05/2026 at 06:30, 1 month 22 days ago Changes to Siegfried's Board of Directors Siegfried announces nomination of Thomas Wozniewski and Karl Petersson to the Board of Directors. Changes in leadership at the Siegfried AG Board Of Directors Leadership Siegfried Thomas Wozniewski Karl Petersson
BRIEF published on 01/27/2026 at 06:35, 1 month 30 days ago Siegfried augmente la capacité de production de substances médicamenteuses aux États-Unis Marché Pharmaceutique Croissance Et Rentabilité Stratégie EVOLVE+ Acquisition De Siegfried Capacités Pharmaceutiques Des États-Unis
BRIEF published on 01/27/2026 at 06:35, 1 month 30 days ago Siegfried Expands US Drug Substance Capacity Pharmaceutical Market Growth And Profitability EVOLVE+ Strategy Siegfried Acquisition US Drug Capacity
PRESS RELEASE published on 01/27/2026 at 06:30, 2 months ago Siegfried to acquire high-quality small molecules drug substance capacity in the US Siegfried, a global CDMO, acquires Noramco Group and Extractas Bioscience for small molecules drug substance capacity in US, strengthening presence and expanding capabilities Acquisition CDMO US Siegfried Small Molecules
BRIEF published on 11/17/2025 at 07:05, 4 months 9 days ago Siegfried AG Announces CFO Transition Pharmaceutical Industry CFO Transition Siegfried AG Tania Micki Reto Suter
Published on 03/26/2026 at 23:00, 7 hours 31 minutes ago FutureGen Industries Announces Closing of Debt Settlement
Published on 03/26/2026 at 22:05, 8 hours 26 minutes ago BlackBerry to Announce Fourth Quarter and Fiscal Year 2026 Results on April 9, 2026
Published on 03/26/2026 at 22:00, 8 hours 31 minutes ago Clean Air Metals Receives Provincial Funding and Provides Update on the Thunder Bay North Project
Published on 03/26/2026 at 22:00, 8 hours 31 minutes ago Green Bridge Metals Reports Visible Copper Sulfide Mineralization in Initial 2026 Titac Drilling, Duluth Complex Minnesota
Published on 03/26/2026 at 21:00, 9 hours 31 minutes ago Worksport Reports Record FY 2025 Results, Issues $35M–$42M 2026 Revenue Guidance; Targets Initial Cash Flow Positivity
Published on 03/27/2026 at 06:00, 30 minutes ago Fewer orders and lower sales - US tariffs, currency effects and cost pressure weigh on earnings
Published on 03/27/2026 at 05:15, 1 hour 15 minutes ago Neapco Holdings LLC Announces the Official Close of IFA Group Acquisition, Creating a Global Leader in Driveline Solutions
Published on 03/27/2026 at 04:00, 2 hours 31 minutes ago Tech-Driven Restoration: Saving the World's Critically Endangered White-headed Langur
Published on 03/26/2026 at 20:48, 9 hours 42 minutes ago Dermapharm Holding SE repurchases 4,299,190 shares under its public share buyback offer
Published on 03/26/2026 at 19:20, 11 hours 10 minutes ago Critical Path Institute Launches 'One to Millions' to Reshape the Future of Individualized Medicine at Global Scale
Published on 03/26/2026 at 18:17, 12 hours 14 minutes ago Eiffage se renforce au capital de Getlink et porte sa participation à 29,40 % du capital
Published on 03/26/2026 at 18:17, 12 hours 14 minutes ago Eiffage strengthens its position in Getlink capital
Published on 03/26/2026 at 18:00, 12 hours 31 minutes ago Arrêté des comptes au 31 décembre 2025 et perspectives 2026
Published on 03/26/2026 at 18:00, 12 hours 31 minutes ago LABORATOIRES EUROMEDIS - Fin du contrat de liquidité
